Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Inks Screening Deal with SuperGen

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has inked an agreement with SuperGen, under which it will provide screening services for the biopharmaceutical firm's drug candidates using its X-MAN technology.

The Cambridge, UK-based firm said that the deal covers the screening of lead compounds on a wide panel of human isogenic cell lines that comprise target genotypes of interest to SuperGen. The X-MAN technology may enable SuperGen to obtain information about the selectivity and mode-of-action of its compounds using model in vitro systems, said Horizon.

Under terms of the alliance, SuperGen will pay Horizon undisclosed fees. The partners expect to begin the collaboration this month.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.